Search clinical trials for: WCK 2349 Oral

Total 8350 results

Wockhardt

Completed

Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of Oral WCK 2349

Pharmacokinetics
Wockhardt
Clinartis

Completed

Study to Determine and Compare Plasma and Intrapulmonary Pharmacokinetics of WCK 2349 in Healthy Adult Human Subjects

Intrapulmonary Pharmacokinetics of WCK 2349

United States
Wockhardt

Completed

Pharmacokinetics of WCK 2349 In Patients With Hepatic Impairment

Hepatic Impairment

United States
Hoffmann-La Roche

Completed

Study of Ro 205-2349 in Patients With Type 2 Diabetes Mellitus

Diabetes

United States, Panama, Mexico, Canada, Estonia, Lithuania, Bulgaria, Romania, Latvia, Puerto Rico, United Kingdom
TaiGen Biotechnology Co., Ltd.

Completed

A Study to Evaluate the Safety, Tolerability, and PK in Healthy Volunteers and HCV Genotype 1 Infected Patients

Healthy | Hepatitis C, Chronic

United States
Wockhardt

Completed

Study to Evaluate the Effect Of WCK 2349 on the QT/QTc Interval in Health Volunteers

Qt Interval, Variation in

United States
Monte Rosa Therapeutics, Inc

Recruiting

Study of Oral MRT-2359 in Selected Cancer Patients

NSCLC | Prostate Cancer | SCLC | DLBCL | High Grade Neuroendocrine Cancer | L-MYC and N-MYC Amplified Solid Tumors | NSCLC With High or Low L-MYC or N-MYC Expression | HR-positive, HER2-negative Breast Cancer

United States, Canada
Dongguan HEC TaiGen Biopharmaceuticals Co., Ltd.
R&G Pharma Studies Co.,Ltd.

Completed

To Evaluate the Safety, Tolerability, and Pharmacokinetics Profile in Healthy Chinese Volunteers of TG-2349

Healthy Chinese Volunteers

China
TaiGen Biotechnology Co., Ltd.

Completed

Study to Evaluate the PK, Relative Bioavailability and Safety of TG-2349 With Single Oral Dose Under Fed Condition in Healthy Volunteers

Healthy

United States
Dongguan HEC TaiGen Biopharmaceuticals Co., Ltd.
Peking University People's Hospital

Completed

To Evaluate Efficacy and Safety in TG-2349 Combination With DAG181 (± Ribavirin) in HCV Genotype I Infected Patients

Cirrhosis | Chronic Hepatics C Virus (HCV) Genotype 1 | Non-Cirrhotic | Treatment naïve

China
Ascentage Pharma Group Inc.
Suzhou Yasheng Pharmaceutical Co., Ltd.

Recruiting

APG-2449 in Patients With Advanced Solid Tumors

Esophageal Cancer | Ovarian Cancer | Non Small Cell Lung Cancer | Malignant Pleural Mesothelioma | Advanced Solid Cancer

China
Genentech, Inc.

Completed

Evaluating the Safety and Tolerability of GDC-0349 in Patients With Locally Advanced or Metastatic Solid Tumors or Non Hodgkin's Lymphoma

Non-Hodgkin's Lymphoma, Solid Tumor

Canada, United States
Kyowa Kirin, Inc.

Terminated

An Ascending Dose Study of KW-2449 in Acute Leukemias, Myelodysplastic Syndromes, and Chronic Myelogenous Leukemia

Myelodysplastic Syndromes | Acute Lymphoblastic Leukemia | Acute Myelogenous Leukemia | Chronic Myelogenous Leukemia

United States
Dongguan HEC TaiGen Biopharmaceuticals Co., Ltd.
R&G Pharma Studies Co.,Ltd.

Completed

To Evaluate PK and Safety Profile of Oral MAD of Separately Using TG-2349, DAG181 or Combination in Healthy Chinese Volunteers

Healthy Chinese Volunteers

China
Kyowa Kirin Co., Ltd.

Terminated

Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Study of KW-2449 in Acute Myelogenous Leukemia (AML) (Protocol Number: 2449-US-002)

Acute Myelogenous Leukemia (AML)

United States
Wockhardt

Completed

Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of Intravenous WCK 771

Bioavailability

United States
Wockhardt

Completed

The Safety, Tolerability And Pharmacokinetics Of Single Ascending Doses And The Effect Of Food On Oral WCK 4873 In Healthy Adult Volunteers

Healthy
Wockhardt

Completed

Evaluate The Safety, Tolerability and Pharmacokinetics Of Multiple Ascending Oral Doses Of WCK 4873 In Healthy Adult Volunteers

Healthy
Wockhardt
Quintiles, Inc.

Completed

MAD Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Intravenous Zidebactam in Healthy Adults

Healthy Subjects

United States
Otsuka Pharmaceutical Co., Ltd.

Completed

Dose-ranging Trial of OPC-249 Powder Inhalation in Patients With Pain Due to Osteoporosis

Pain Due to Osteoporosis

Japan
Hoffmann-La Roche

Completed

Study to Determine the Efficacy, Safety, Tolerability & Pharmacokinetics of RO 205-2349 in Patients With Type 2 Diabetes Mellitus

Diabetes

United States, Panama, Mexico, Estonia, Bulgaria, Romania, Puerto Rico, Switzerland, United Kingdom
Novo Nordisk A/S

Withdrawn

Examination of the Safety and Tolerability of NNC 0070-0002-0349 in Overweight/Obese Volunteers

Obesity | Metabolism and Nutrition Disorder
Zhejiang Hisun Pharmaceutical Co. Ltd.

Unknown

Trial of Ginsenoside Compound K (GCK) Tablet in Patients With Rheumatoid Arthritis

Early Rheumatoid Arthritis

China
Wockhardt
Quintiles, Inc.

Completed

MED Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Intravenous WCK 5222 (Zidebactam and Cefepime) in Healthy Volunteers

Serious Gram-negative Infections

United States
University of Lausanne Hospitals

Completed

Safety and Cost-effectiveness Study of Single Port Laparoscopic Cholecystectomies (SPoCOT)

Cholecystolithiasis

Switzerland
Wockhardt

Completed

Evaluate the Effect of WCK 5222 on the QT/QTc Interval in Healthy Volunteers

QT/QTc Interval in Healthy Volunteers

United States
Chong Kun Dang Pharmaceutical

Completed

Clinical Study to Compare the Pharmacokinetics and Safety of D113 With CKD-349 in Healthy Volunteers

Chronic Renal Failure

Korea, Republic of
Zoll Medical Corporation

Completed

Heart Sounds Registry (HEARIT-Reg)

Heart Failure; With Decompensation

United States, Austria, Germany, Poland
Chong Kun Dang Pharmaceutical

Completed

Study to Evaluate the Safety and Pharmacokinetics of CKD-349 in Healthy Adult Volunteers

Chronic Heart Failure

Korea, Republic of
Wockhardt
Quintiles, Inc.

Completed

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of WCK 5107 Alone and in Combination With Cefepime

Healthy

United States
American Institute for Cancer Research

Completed

Testing the Effectiveness of Coping With Cancer in the Kitchen (CCK)

Cancer | Nutrition Aspect of Cancer

United States
Dongguan HEC TaiGen Biopharmaceuticals Co., Ltd.

Completed

A Phase III Study to Evaluate Efficacy and Safety of TG-2349 in Combination With DAG181 and RBV for HCV Type I Patients

Cirrhosis | Chronic Hepatics C Virus (HCV) Genotype 1 | Non-Cirrhotic | Treatment naïve

China
National Institute of Allergy and Infectious Diseases...

Completed

Safety Study of Intravenous Ertapenem in Combination With Zidebactam (WCK 6777)

Bacterial Infection

United States
University of Illinois at Chicago
Northwestern University; Northeastern Illinois University

Not yet recruiting

WeCanManage. An mHealth Self-management Tool

Sarcoma | Breast Cancer | Head and Neck Cancer
Teijin America, Inc.
Parexel

Completed

A Study to Investigate Safety, Tolerability, and Pharmacokinetics of Oral Doses of TCK-276 in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

United States
Children's Healthcare of Atlanta

Withdrawn

Wick vs. No Wick: Does Method of Closure Affect Rate of Wound Infection?

Postoperative Wound Infection

United States
Wockhardt
Clinartis

Completed

To Investigate The Pharmacokinetics Of Intravenous WCK 5222 (FEP-ZID) In Patients With Renal Impairment

Renal Impairment

United States
Reinier Haga Orthopedisch Centrum

Not yet recruiting

RSA Restoris MultiCompartmental Knee

Osteoarthritis, Knee
Blood Purification Technologies, Inc.
University of Washington; Wearable Artificial Kidney Foundation

Completed

24 Hour Use of the Wearable Artificial Kidney (WAK US 1)

End Stage Renal Disease

United States
Alaska Blind Child Discovery

Completed

Hyperopia Detection GCK With Glow Fixation

Accommodation Disorder | Hyperopia of Both Eyes | Astigmatism Bilateral | Amblyopia Bilateral

United States
Maxx Orthopedics Inc

Recruiting

Maxx Orthopedics' PCK Revision TKA Study of Component Survivorship

Bone Loss | Periprosthetic Fractures | Infection | Aseptic Loosening | MCL - Medial Collateral Ligament Rupture of the Knee

United States
The University of Texas Health Science Center,...
Robert Cizik Eye Clinic

Terminated

Evaluating the Efficacy of Fenestrations in Tube Shunt Implants During the Early Postoperative Period

Glaucoma

United States
Wayne State University
Children's Hospital of Michigan; American Regent, Inc.

Withdrawn

IV Iron Sucrose vs Oral FeSO4 in Treating IDA in Pediatric IBD

Iron Deficiency Anemia | Inflammatory Bowel Disease

United States
Nephron Pharmaceuticals Corporation

Completed

Safety and Efficacy of T-2345 Compared to Xalatan in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension

Primary Open Angle Glaucoma | Ocular Hypertension

United States
Rasmia Elgohary

Not yet recruiting

Evaluation of the Effect of Wet Cupping (Hijama) on Primary Fibromyalgia

Treatment
Zoll Medical Corporation

Terminated

Wearable Cardioverter Defibrillator in Hemodialysis Patients (WED-HED) Study (WED-HED)

Sudden Cardiac Death | Sudden Cardiac Arrest

United States
National Institute of Allergy and Infectious Diseases...

Completed

Safety Study of Hepatitis E Vaccine (HEV239)

Hepatitis E | Immunisation

United States
Zoll Medical Corporation
University of Rochester

Completed

LifeVest Wearable Cardioverter Defibrillator WEARIT-III Registry (WEARIT-III)

Ischemic Heart Failure

United States
Texas Tech University Health Sciences Center

Terminated

Ultrasound for Diagnosis of Biliary Dyskinesia

Biliary Dyskinesia

United States
Helsingborgs Hospital
Skane University Hospital; Lund University Hospital

Completed

A Device Designed to Protect the Perineum During Labor

Perineal Tear

Sweden

Search clinical trials for: WCK 2349 Oral

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovakia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations